Back to User profile » Dr Xi Li

Papers published by Dr Xi Li:


Significant Benefits of Afatinib and Apatinib in a Refractory Advanced NSCLC Patient Resistant to Osimertinib: A Case Report

Zhao Y, Chen Y, Huang H, Li X, Shao L, Ding H

OncoTargets and Therapy 2021, 14:3063-3067

Published Date: 7 May 2021

Combination of Osimertinib and Anlotinib May Overcome the Resistance Mediated by in cis EGFR T790M-C797S in NSCLC: A Case Report

Zhou R, Song L, Zhang W, Shao L, Li X, Li X

OncoTargets and Therapy 2021, 14:2847-2851

Published Date: 28 April 2021